ECO Animal Health Group plc (EAH.L), a biotech company, Monday reported a net profit for the first half, compared to net loss last year, reflecting higher revenues.
On the London Stock Exchange, shares were trading 5.85% higher at 99.50 pence.
Looking ahead, the group said, "We continue to expect an H2 weighting for FY 2026, due to historically observed higher demand for Aivlosin associated with the Northern Hemisphere winter." The Board looks forward with confidence to reporting the full year numbers in line with market expectations.
Market consensus for the full year is understood to be revenue of 83.8 million pounds and adjusted EBITDA of 7.7 million pounds.
For the first half, the company reported a profit before tax of 1.06 million pounds or 0.54 pence per share, compared to a loss of 1.42 million pounds or 2.50 pence per share last year.
The firm's adjusted EBITDA was 2.96 million pounds, up from 0.445 million pounds the prior year period.
The animal health biotech company's group revenue increased 19% to 39.40 million pounds from 33.18 million pounds for the comparable period last year. Revenues on a constant currency basis increased 23%
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.